Production at Odisha first vaccine manufacturing plant to commence by May

The facility is expected to produce over 15 vaccines for various diseases, including cholera and malaria.

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-02-19 08:00 GMT   |   Update On 2024-03-22 09:36 GMT

Odisha: Commercial production at the Sapigen Biologix vaccine plant in Odisha, the first such facility in the state, will commence by May this year, officials said on Sunday.The plant at the Biotech Park in Andharua near here will have a capacity to produce 2.4 crore doses of different vaccines per day, they said.At full capacity, this facility will be the biggest vaccine-producing plant in...

Login or Register to read the full article

Odisha: Commercial production at the Sapigen Biologix vaccine plant in Odisha, the first such facility in the state, will commence by May this year, officials said on Sunday.

The plant at the Biotech Park in Andharua near here will have a capacity to produce 2.4 crore doses of different vaccines per day, they said.
At full capacity, this facility will be the biggest vaccine-producing plant in the country, the Chief Minister's Office (CMO) said in a statement.
It is expected to produce over 15 vaccines for various diseases, including cholera and malaria.
The Rs 1,500-crore vaccine plant will create direct employment for 1,500 people, with most of them being local recruits, the CMO said.
The variety of vaccines produced in Bhubaneswar will be supplied to many parts of the world, it added.
V K Pandian, the chairman of '5T' technology-led transformative initiatives on Sunday visited the sub-units and interacted with the management and employees. He urged all government agencies to assist in the commissioning of the plant within the next three months.

Read also: USFDA accepts under priority review GSK application to extend indication of adjuvanted RSV vaccine


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News